0

Gastroenterology/Hepatology Collection
 301-320 of 2642 Articles
Articles |  7 November 2000
Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis
John B. Wong, MD; Raymond S. Koff, MD
Ann Intern Med. 2000;133(9):665-675. doi:10.7326/0003-4819-133-9-200011070-00008
Editorials |  17 October 2000
Prevention and Treatment of Colorectal Cancer: Pay Now or Pay Later
James D. Lewis, MD, MSCE
Ann Intern Med. 2000;133(8):647-649. doi:10.7326/0003-4819-133-8-200010170-00017
Articles |  17 October 2000 FREE
Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer
Amnon Sonnenberg, MD, MSc; Fabiola Delcò, MD, MPH; John M. Inadomi, MD
Ann Intern Med. 2000;133(8):573-584. doi:10.7326/0003-4819-133-8-200010170-00007
Articles |  5 September 2000
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
Ernest Beutler, MD; Vincent Felitti, MD; Terri Gelbart, BS; et al.
Ann Intern Med. 2000;133(5):329-337. doi:10.7326/0003-4819-133-5-200009050-00008
Articles |  15 August 2000
Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes
Elif Arioglu, MD; Jennifer Duncan-Morin, RN; Nancy Sebring, RD; et al.
Ann Intern Med. 2000;133(4):263-274. doi:10.7326/0003-4819-133-4-200008150-00009
Editorials |  1 August 2000
The Burning Issue of Chronic Gastroesophageal Reflux
Glenn M. Eisen, MD, MPH
Ann Intern Med. 2000;133(3):227-229. doi:10.7326/0003-4819-133-3-200008010-00016
Brief Communications |  1 August 2000 FREE
Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases
Kirk D. Miller, MD; Miriam Cameron, MD; Lauren V. Wood, MD; et al.
Ann Intern Med. 2000;133(3):192-196. doi:10.7326/0003-4819-133-3-200008010-00010
Articles |  1 August 2000
Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma
Jesper Lagergren, MD, PhD; Reinhold Bergström, PhD; Hans-Olov Adami, MD, PhD; et al.
Ann Intern Med. 2000;133(3):165-175. doi:10.7326/0003-4819-133-3-200008010-00007
Reviews |  18 July 2000
Pharmacologic Treatment of the Irritable Bowel Syndrome: A Systematic Review of Randomized, Controlled Trials
Jeegar Jailwala, MD; Thomas F. Imperiale, MD; Kurt Kroenke, MD
Ann Intern Med. 2000;133(2):136-147. doi:10.7326/0003-4819-133-2-200007180-00013
Abroad |  20 June 2000 FREE
A Multiyear Prospective Study of the Risk Factors for and Incidence of Diarrheal Illness in a Cohort of Peace Corps Volunteers in Guatemala
Barbara L. Herwaldt, MD, MPH; Kathleen R. de Arroyave, BSN, RN; Jacquelin M. Roberts, MS; et al.
Ann Intern Med. 2000;132(12):982-988. doi:10.7326/0003-4819-132-12-200006200-00009
Reviews |  2 May 2000
Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium
Arshad H. Malik, MD; William M. Lee, MD
Ann Intern Med. 2000;132(9):723-731. doi:10.7326/0003-4819-132-9-200005020-00007
Articles |  18 April 2000
Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus
Rebecca E. Rudolph, MD, MPH; Thomas L. Vaughan, MD, MPH; Barry E. Storer, PhD; et al.
Ann Intern Med. 2000;132(8):612-620. doi:10.7326/0003-4819-132-8-200004180-00003
Articles |  4 April 2000
Prevalence of Liver Disease and Contributing Factors in Patients Receiving Home Parenteral Nutrition for Permanent Intestinal Failure
Maryan Cavicchi, MD; Philippe Beau, MD; Pascal Crenn, MD; et al.
Ann Intern Med. 2000;132(7):525-532. doi:10.7326/0003-4819-132-7-200004040-00003
Articles |  4 April 2000
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy
Yasushi Shiratori, MD; Fumio Imazeki, MD; Mitsuhiko Moriyama, MD; et al.
Ann Intern Med. 2000;132(7):517-524. doi:10.7326/0003-4819-132-7-200004040-00002
Brief Communications |  15 February 2000
Positive Results on Tests for Steatorrhea in Persons Consuming Olestra Potato Chips
Ranga Balasekaran, MD; Jack L. Porter, MS; Carol A. Santa Ana, BS; et al.
Ann Intern Med. 2000;132(4):279-282. doi:10.7326/0003-4819-132-4-200002150-00005
Reviews |  18 January 2000
Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity?
Mark Feldman, MD; Alexander T. McMahon, MBA
Ann Intern Med. 2000;132(2):134-143. doi:10.7326/0003-4819-132-2-200001180-00008
Brief Communications |  18 January 2000
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Jameela Al-Salman, MD; Heider Arjomand, MD; David G. Kemp, MD; et al.
Ann Intern Med. 2000;132(2):121-124. doi:10.7326/0003-4819-132-2-200001180-00006
Brief Communications |  18 January 2000
Hepatic Failure in a Patient Taking Rosiglitazone
Lisa M. Forman, MD; David A. Simmons, MD; Robert H. Diamond, MD
Ann Intern Med. 2000;132(2):118-121. doi:10.7326/0003-4819-132-2-200001180-00005
Articles |  18 January 2000
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Stefano Bellentani, MD, PhD; Gioconda Saccoccio, MD; Flora Masutti, MD; et al.
Ann Intern Med. 2000;132(2):112-117. doi:10.7326/0003-4819-132-2-200001180-00004
Brief Communications |  21 December 1999
Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series
Christoph Schramm, MD; Peter Schirmacher, MD; Ilka Helmreich-Becker, MD; et al.
Ann Intern Med. 1999;131(12):943-946. doi:10.7326/0003-4819-131-12-199912210-00006
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)